Collectively, these findings suggest that DEHP might improve the hepatic levels of IL-6 and CXCL1 via the 14-3-3η/NF-κB feedback loop, leading to HOD induction. This evidence concerns the gene CXCL1 and hypopigmentation, organomegaly, and delayed myelination and development.